Skip to main content
GutCited

Bifidobacterium longum cho Irritable Bowel Syndrome (IBS)

B

RCTs demonstrate significant reduction in IBS composite symptom score versus placebo. Particular benefit for bloating and abdominal distension. Marketed as Alflorex/Align.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dlongum\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Kết luận

RCTs demonstrate significant reduction in IBS composite symptom score versus placebo. Particular benefit for bloating and abdominal distension. Marketed as Alflorex/Align.

Key Study Findings

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None so với: placebo Outcome: quality of life, depression, and anxiety in IBS … Hiệu quả: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

Đối tượng nghiên cứu: patients with irritable bowel syndrome

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None so với: placebo Outcome: improvement in key IBS symptoms Hiệu quả: None None

Đối tượng nghiên cứu: patients with IBS from 32 RCTs evaluating 10 probiotic strains

In Vitro n=35
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum …
Dose: 1e6 CFU/mL so với: IBS supernatants without probiotic Outcome: Caco-2 paracellular permeability Hiệu quả: None <0.001

Đối tượng nghiên cứu: IBS patients (28) and asymptomatic controls (7)

Review
The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review.
Dose: None so với: None Outcome: IBS symptom management via NLRP3 inhibition Hiệu quả: None None

Đối tượng nghiên cứu: Patients with IBS (narrative review)

Controlled Clinical Trial n=51 12 weeks Open-label
Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and …
Dose: None so với: Pre-treatment baseline Outcome: IBS-SSS score reduction Hiệu quả: None None

Đối tượng nghiên cứu: IBS-D and IBS-C patients

Observational Study n=37 8 weeks Open-label
An 8-Week Course of Bifidobacterium longum 35624® Is Associated with a Reduction in the Symptoms …
Dose: None so với: None Outcome: Total IBS symptom score (TISS) Hiệu quả: 43.4% TISS reduction; >60% >=30% responders None

Đối tượng nghiên cứu: Adults with IBS (Rome IV criteria)

Key Statistics

4

Nghiên cứu

600

Người tham gia

Positive

B

Xếp hạng

Referenced Papers

Terapevticheskii arkhiv 2023 3 trích dẫn
The Cochrane database … 2020 14 trích dẫn
Journal of gastroenterology … 2017 32 trích dẫn

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Liều lượng thường dùng

general:
1-10 billion CFU/day
ibssupport:
1 billion CFU/day (35624 strain, marketed as Alflorex/Align)

Giới hạn trên: Well-tolerated up to 10 billion CFU/day in clinical trials

Liều lượng đã nghiên cứu

Liều lượng Thời gian Hiệu quả N
None -- Positive 3154
None -- Positive --
1e6 CFU/mL -- Positive 35
None -- Positive --
None 12 weeks Positive 51
None 8 weeks Positive 37
1x10^10 CFU daily 6 weeks Positive 35
2 g 4 weeks Mixed --

Thời điểm dùng tốt nhất: On an empty stomach or before meals

Safety & Side Effects

Tác dụng phụ đã được báo cáo

  • Mild gas and bloating during initial use
  • Occasional abdominal discomfort
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

Tương tác đã biết

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (use with caution in immunocompromised patients)

Mức hấp thụ tối đa cho phép: Well-tolerated up to 10 billion CFU/day in clinical trials

Luôn tham khảo ý kiến bác sĩ trước khi bắt đầu sử dụng bất kỳ thực phẩm bổ sung nào.Luôn tham khảo ý kiến chuyên gia y tế trước khi sử dụng bất kỳ thực phẩm chức năng nào.

Frequently Asked Questions

Does Bifidobacterium longum help with Irritable Bowel Syndrome (IBS)?
Based on 4 studies with 600 participants, there is moderate evidence from clinical studies that Bifidobacterium longum may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Bifidobacterium longum should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bifidobacterium longum?
Reported side effects may include Mild gas and bloating during initial use, Occasional abdominal discomfort, Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bifidobacterium longum and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

Tuyên bố miễn trừ FDA: Các tuyên bố này chưa được Cục Quản lý Thực phẩm và Dược phẩm (FDA) đánh giá. Các sản phẩm và thông tin trên trang web này không nhằm mục đích chẩn đoán, điều trị, chữa bệnh hoặc phòng ngừa bất kỳ bệnh nào. Xếp hạng bằng chứng được trình bày dựa trên phân tích của chúng tôi về nghiên cứu đã bình duyệt được công bố và không cấu thành tư vấn y khoa. Luôn tham khảo ý kiến chuyên gia y tế trước khi bắt đầu bất kỳ chế độ thực phẩm chức năng nào.